EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Strategies Used for the Discovery of New Microbial Metabolites with Antibiotic Activity

Pablo Dasí-Delgado, Cecilia Andreu iD, Marcel Lí Del Olmo iD

Molecules · 06.07.2025 · 30 (13) · 2868

DOI: 10.3390/molecules30132868 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Molecules, online erschienen am 06.07.2025. Verfasst von Pablo Dasí-Delgado und 2 weiteren Autor:innen. Beteiligte Einrichtung: Departament de Bioquímica i Biologia Molecular, Universitat de València (UVEG), Dr. Moliner 50, E-46100 Burjassot, València, Spain. Hauptthemen laut MEDLINE: Anti-Bacterial Agents, Drug Discovery, Bacteria. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 137 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The discovery of new microbial metabolites is essential to combat the alarming rise in antimicrobial resistance and to meet emerging medical needs. This work critically reviews current strategies for identifying antimicrobial compounds, emphasizing the potential of microorganisms as a rich source of bioactive secondary metabolites. This review explores innovative methods, such as investigating extreme environments where adverse conditions favor the emergence of unique metabolites; developing techniques, like the iChip, to cultivate previously uncultivable bacteria; using metagenomics to analyze complex samples that are difficult to isolate; and integrates artificial intelligence to accelerate genomic mining, structural prediction, and drug discovery optimization processes. The importance of overcoming current challenges, such as replicating findings, low research investment, and the lack of adapted collection technologies, is also emphasized. Additionally, this work analyzes the crucial role of bacterial resistance and the necessity of a holistic approach involving new technologies, sustained investment, and interdisciplinary collaboration. This work emphasizes not only the current state of metabolite discovery but also the challenges that must be addressed to ensure a continuous flow of new therapeutic molecules in the coming decades.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Anti-Bacterial AgentsDrug DiscoveryBacteriaMetagenomicsHumansDrug Resistance, Bacterial

Stichwörter der Autor:innen

antibioticantimicrobial resistanceartificial intelligencedrug discoveryextremophilesisolation Chipmetagenomicsmicroorganismsnatural productssecondary metabolites

Substanzen

Anti-Bacterial Agents

Autor:innen und Institutionen

  • Departament de Bioquímica i Biologia Molecular, Universitat de València (UVEG), Dr. Moliner 50, E-46100 Burjassot, València, Spain.
  • Departament de Química Orgànica, Universitat de València (UVEG), Vicent Andrés Estellés s.n., E-46100 Burjassot, València, Spain.

ORCID-Profile: Cecilia Andreu, Marcel Lí Del Olmo

Zitieren

APA

Dasí-Delgado, P., Andreu, C., & Del Olmo, M. L. (2025). Strategies Used for the Discovery of New Microbial Metabolites with Antibiotic Activity. Molecules, 30(13), 2868. https://doi.org/10.3390/molecules30132868

Vancouver

Dasí-Delgado P, Andreu C, Del Olmo ML. Strategies Used for the Discovery of New Microbial Metabolites with Antibiotic Activity. Molecules. 2025;30(13):2868. doi:10.3390/molecules30132868

BibTeX
@article{DasDelgado2025,
  author = {Dasí-Delgado, Pablo and Andreu, Cecilia and Del Olmo, Marcel Lí},
  title = {Strategies Used for the Discovery of New Microbial Metabolites with Antibiotic Activity},
  journal = {Molecules},
  year = {2025},
  volume = {30},
  number = {13},
  pages = {2868},
  doi = {10.3390/molecules30132868}
}
Kostenlos starten →